Originally posted by pe981
Not sure what doesn't make sense, but I'll try again:-
- Whether retail holders should get the opportunity to participate in raising is open to debate however I think when you have legitimate 3rd parties stumping up some funds holders don't mind, but when half of the raising is from the Bod / Management it can create questions!!
- Cooper and Cairns Company C2V were issued 75m shares under a placement @ 2c earlier this year and are now being issued another 83m+ odd @ 3c for a total of 158m+ which will be approx 22% of new total share no of 715m (just using round numbers for ease)
- This placement has been issued under listing rules 7.1 & 7.4. Approval of Res 4 at AGM allowed for an additional 10% placement (over and above normal 15%) which obviously they have calculated the 183m share issue fits.
- The 20% rule prevents a shareholder taking more than 20% of issued capital without lodging a takeover or be subject to an exception. One of the main exceptions would be shareholder approval, however shareholders are not being given the opportunity to have a say and ann is totally silent on the fact C2V will hold in excess of 20%clear.png
Shareholders may well be happy with all of that, however placement of significant percentages to associated entities of those in control should, to my mind, be subject to much more rigorous analysis than just saying it's ok because we now have $5m in the bank.
Dilution is something holders have to put up with in Companies like this but sometimes it is worth looking at the other side - in this case the rise of C2V shareholdings and their intentions.
Remember Cooper & Co must have a better understanding of the investment in InHealth other than the nondescript comments we have been provided on that Company!!
From Craig Cooper - CEO of CardieX Limited
Our (C2V's) intentions are the same as all shareholders - to build value in the company and provide a return to all shareholders, and yes, that includes for executives and management. There is nothing vague about the disclosures around inHealth Medical as all information has been fully provided to the market as required. To the contrary, based on the information that has been fully disclosed, the market still doesn't seem to see the scale of the opportunity that has been fully outlined publicly. C2V investing a substantial position of the raise is a sign of confidence in the strategy and vision we have for the company. This is not about denying "small shareholders" an opportunity as you have the same opportunity as everyone else to buy stock in the company at or near the current prices we have. And if you shared our long term vision for the company a 1/10th to 2/10th of a cent price variation from the issue price should be irrelevant. We need shareholders on our register that share our long term vision - it's a marathon not a (trading) sprint and we prefer shareholders with endurance who understand what we are building. You assume in your post that we were issued shares as some form of "gift" whereas we (C2V) have been the main financial supporters of the company since we became involved and have been responsible for its turnaround based on the cold cash injections we have personally made - totaling over $4M to date - of which $3M is being used from the current funding to fund the inHealth transaction. C2V corner-stoned this recent funding to send a positive signal to the market - in a difficult trading and funding environment in falling global markets in the circumstances where the company needed immediate funding for the inHealth transaction. You talk of the "rise of C2V and our intentions" as if we are some alien force looking to take over the company and extinguish all that get in our way as we move to 20%! And you refer to our inHealth disclosures as "nondescript" and "vague and sketchy". Have you read our 42 page investor update that we recently released? Did you listen to my 45 minute podcast on the inHealth transaction that we released to the market? Did you analyze the draft financials in the inHealth transaction overview that we also released? Have you analyzed the Kaiser Permanente deal or our disclosures around our partnerships with Anthem and American Well? I don't know what more you need? You have all the information to make an informed decision as to whether to buy, sell, or hold. It's not an "us v them" scenario as you are implying. Don't assume there is some alternative paranoid agenda everywhere. C2V's intention is the same as yours, to drive shareholder value - yours - and mine included as the largest shareholder. Read the press releases, of which there have been many. You are asking for more news to drive the share price? I would suggest you properly analyze the last few months releases and fully digest what we are doing and the significance of it all and then decide whether to remain a shareholder or not either way. I am certainly staying around. We have voted with our own wallets. Would you be happier if I put no money into the company while at the same time asking large supporting institutions and other shareholders to do so? Or if we handed the placement out to the denizens of traders we seem to have on our register that we are slowly weeding out from the companies AtCor legacy days? What message does that send? A better one? Show me other directors/CEO's of similar small-cap companies that have financially supported at the same level we have done in the same circumstances? You have the opportunity to join us or not in our journey at a comparable price as we position the company for the future. Questioning the motives of management and executives rather than focusing on the opportunities we have with inHealth and our other business units is not a productive and valuable use of energy - particularly given all the work and effort that is going into making this company a success for all shareholders. All my best, Craig Cooper (CEO- CardieX Limited).
(20min delay)
